Sweden - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Sweden Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes grew 1.7% year on year. At €272.33 Per Capita in 2019, the country was number 11 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Sweden is overtaken by Norway, which was number 10 at €282.56 Per Capita and is followed by Finland with €266.78 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, that is an increase of 3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +8.8% per year, while Romania recorded the worst performance at -1.7% per year.

Loading...

Date Euros Per Capita
2019 272.33
2018 269.35
2017 272.03
2016 277.54
2015 253.91
Download all data from 2001 to 2019

How does Sweden rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
10 #10
Norway
282.56 2019 +0.7 % -0.5 % View data
11 #11
Sweden
272.33 2019 +1.1 % +1.7 % View data
12 #12
Finland
266.78 2019 +0.8 % +2.2 % View data
Compare all 33 countries

Go Top